CoChat

Cek1 regulates ß(1,3)-glucan exposure through calcineurin effectors in Candida albicans

Open access

The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.

Abstract

In order to successfully induce disease, the fungal pathogen Candida albicans regulates exposure of antigens like the cell wall polysaccharide ß(1,3)-glucan to the host immune system. C . albicans covers (masks) ß(1,3)-glucan with a layer of mannosylated glycoproteins, which aids in immune system evasion by acting as a barrier to recognition by host pattern recognition receptors. Consequently, enhanced ß(1,3)-glucan exposure (unmasking) makes fungal cells more visible to host immune cells and facilitates more robust fungal clearance. However, an understanding of how C . albicans regulates its exposure levels of ß(1,3)-glucan is needed to leverage this phenotype. Signal transduction pathways and their corresponding effector genes mediating these changes are only beginning to be defined. Here, we report that the phosphatase calcineurin mediates unmasking of ß(1,3)-glucan in response to inputs from the Cek1 MAPK pathway and in response to caspofungin exposure. In contrast, calcineurin reduces ß-glucan exposure in response to high levels of extracellular calcium. Thus, depending on the input, calcineurin acts as a switchboard to regulate ß(1,3)-glucan exposure levels. By leveraging these differential ß(1,3)-glucan exposure phenotypes, we identified two novel effector genes in the calcineurin regulon, FGR41 and C1_11990W_A , that encode putative cell wall proteins and mediate masking/unmasking. Loss of either effector caused unmasking and attenuated virulence during systemic infection in mice. Furthermore, immunosuppression restored the colonization decrease seen in mice infected with the fgr41Δ/Δ mutant to wild-type levels, demonstrating a reliance on the host immune system for virulence attenuation. Thus, calcineurin and its downstream regulon are general regulators of unmasking.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pgen.1010405

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Calcineurin mediates hyperactive Ste11ΔN467-induced and caspofungin-induced unmasking in C. albicans. (A) Disruption of the Dfi1-calmodulin interaction reduces Ste11ΔN467-induced unmasking. Cells from overnight cultures were stained with an anti-ß(1,3)-glucan antibody and a phycoerythrin-conjugated secondary antibody, and flow cytometry analysis was used to assess the levels of ß(1,3)-glucan exposure. (n = 3 biological replicates with 1 technical replicate for each)(****p<0.0001, by one-way ANOVA). (B) Cyclosporine A inhibition of calcineurin reduces Ste11ΔN467-induced unmasking. The SC5314 wild-type or the STE11/Ptet-off-STE11ΔN467 mutant was grown overnight in either the presence of 100μg/ml of cyclosporine A or an appropriate volume of the DMSO solvent control, and ß(1,3)-glucan exposure was assessed via flow cytometry. (n = 3 biological replicates with 1 technical replicate for each)(**p<0.005, ****p<0.0001, by one-way ANOVA). (C-D) Genes that are necessary for Ste11ΔN467-induced unmasking were tested for their roles in caspofungin-induced unmasking by treating cells grown to mid-log phase with 46.9ng/ml of caspofungin for 30 minutes followed by flow cytometry. (C) ß(1,3)-glucan unmasking in cph1Δ/Δ cells treated with sublethal concentrations of caspofungin. (n = 3 biological replicates)(****p<0.0001, by one-way ANOVA). (D) ß(1,3)-glucan unmasking in dfi1Δ/Δ cells treated with sublethal concentrations of caspofungin. (n = 3 biological replicates)(***p = 0.0005, ****p<0.0001, by one-way ANOVA). (E) Calcineurin inhibition attenuates caspofungin-induced unmasking. SC5314 wild-type cells grown to mid-log phase in either the presence of 100μg/ml of cyclosporine A, or an appropriate volume of the DMSO solvent control, were exposed to 46.9ng/ml of caspofungin or ethanol control for 30 minutes, and ß(1,3)-glucan exposure was measured via flow cytometry. (n = 3 biological replicates)(*p<0.05, **p<0.01, ***p<0.0005, by one-way ANOVA). (F) Representative histogram of the impact that cyclosporine A-mediated calcinuerin inhibition has on caspofungin induced ß(1,3)-glucan exposure. Colors of each sample match those shown in 1E.
Fig 1 Calcineurin mediates hyperactive Ste11ΔN467-induced and caspofungin-induced unmasking in C. albicans. (A) Disruption of the Dfi1-calmodulin interaction reduces Ste11ΔN467-induced unmasking. Cells from overnight cultures were stained with an anti-ß(1,3)-glucan antibody and a phycoerythrin-conjugated secondary antibody, and flow cytometry analysis was used to assess the levels of ß(1,3)-glucan exposure. (n = 3 biological replicates with 1 technical replicate for each)(****p<0.0001, by one-way ANOVA). (B) Cyclosporine A inhibition of calcineurin reduces Ste11ΔN467-induced unmasking. The SC5314 wild-type or the STE11/Ptet-off-STE11ΔN467 mutant was grown overnight in either the presence of 100μg/ml of cyclosporine A or an appropriate volume of the DMSO solvent control, and ß(1,3)-glucan exposure was assessed via flow cytometry. (n = 3 biological replicates with 1 technical replicate for each)(**p<0.005, ****p<0.0001, by one-way ANOVA). (C-D) Genes that are necessary for Ste11ΔN467-induced unmasking were tested for their roles in caspofungin-induced unmasking by treating cells grown to mid-log phase with 46.9ng/ml of caspofungin for 30 minutes followed by flow cytometry. (C) ß(1,3)-glucan unmasking in cph1Δ/Δ cells treated with sublethal concentrations of caspofungin. (n = 3 biological replicates)(****p<0.0001, by one-way ANOVA). (D) ß(1,3)-glucan unmasking in dfi1Δ/Δ cells treated with sublethal concentrations of caspofungin. (n = 3 biological replicates)(***p = 0.0005, ****p<0.0001, by one-way ANOVA). (E) Calcineurin inhibition attenuates caspofungin-induced unmasking. SC5314 wild-type cells grown to mid-log phase in either the presence of 100μg/ml of cyclosporine A, or an appropriate volume of the DMSO solvent control, were exposed to 46.9ng/ml of caspofungin or ethanol control for 30 minutes, and ß(1,3)-glucan exposure was measured via flow cytometry. (n = 3 biological replicates)(*p<0.05, **p<0.01, ***p<0.0005, by one-way ANOVA). (F) Representative histogram of the impact that cyclosporine A-mediated calcinuerin inhibition has on caspofungin induced ß(1,3)-glucan exposure. Colors of each sample match those shown in 1E.CC BY · PubMed Central
Fig 2 Crz1 mediates masking in response to exogenous calcium. (A-B) Cells were grown overnight in the absence or presence of 50mM CaCl2 in YPD broth. Cells were stained with an anti-ß(1,3)-glucan antibody and a phycoerythrin-conjugated secondary antibody followed by flow cytometry to assess the levels of ß(1,3)-glucan exposure. (A) Calcium-induced masking of SC5314 wild-type cells. (n = 3 biological replicates with 1 technical replicate for each) (***p = 0.0002, by student’s t-test). (B) Calcium induced masking of STE11/Ptet-off-STE11ΔN467 cells. (n = 3 biological replicates with 1 technical replicate for each) (****p<0.0001, by student’s t-test). (C) Calcineurin inhibition blocks calcium-induced masking. SC5314 cells were grown overnight in the absence or presence of 50mM CaCl2 and either 100μg/ml of cyclosporine A or an appropriate volume of the DMSO solvent control in YPD media. ß(1,3)-glucan exposure was then assessed via flow cytometry. (n = 3 biological replicates with 1 technical replicate for each)(**p<0.01, ****p<0.0001, by one-way ANOVA). (D) Loss of CRZ1 does not impact Ste11ΔN467-induced unmasking. Overnight cultures were stained for ß(1,3)-glucan exposure and flow cytometry was subsequently run to assess unmasking. (n = 3 biological replicates with 1 technical replicate for each) (ns = not significant, ****p<0.0001, by one-way ANOVA). (E) Loss of CRZ1 does not impact caspofungin-induced unmasking. Cells grown to mid-log phase prior to being exposed to 46.9ng/ml of caspofungin for 30 minutes and ß(1,3)-glucan exposure was subsequently assessed via flow cytometry. (n = 3 biological replicates)(ns = not significant, ****p<0.0001, by one-way ANOVA). (F) Loss of CRZ1 blocks calcium-induced masking. Overnight cultures of cells grown in the absence or presence of 50mM CaCl2 were stained for ß(1,3)-glucan exposure and flow cytometry was subsequently run to assess ß(1,3)-glucan exposure levels. (n = 3 biological replicates with 1 technical replicate for each)(**p<0.01, ****p<0.0001, by one-way ANOVA).
Fig 2 Crz1 mediates masking in response to exogenous calcium. (A-B) Cells were grown overnight in the absence or presence of 50mM CaCl2 in YPD broth. Cells were stained with an anti-ß(1,3)-glucan antibody and a phycoerythrin-conjugated secondary antibody followed by flow cytometry to assess the levels of ß(1,3)-glucan exposure. (A) Calcium-induced masking of SC5314 wild-type cells. (n = 3 biological replicates with 1 technical replicate for each) (***p = 0.0002, by student’s t-test). (B) Calcium induced masking of STE11/Ptet-off-STE11ΔN467 cells. (n = 3 biological replicates with 1 technical replicate for each) (****p<0.0001, by student’s t-test). (C) Calcineurin inhibition blocks calcium-induced masking. SC5314 cells were grown overnight in the absence or presence of 50mM CaCl2 and either 100μg/ml of cyclosporine A or an appropriate volume of the DMSO solvent control in YPD media. ß(1,3)-glucan exposure was then assessed via flow cytometry. (n = 3 biological replicates with 1 technical replicate for each)(**p<0.01, ****p<0.0001, by one-way ANOVA). (D) Loss of CRZ1 does not impact Ste11ΔN467-induced unmasking. Overnight cultures were stained for ß(1,3)-glucan exposure and flow cytometry was subsequently run to assess unmasking. (n = 3 biological replicates with 1 technical replicate for each) (ns = not significant, ****p<0.0001, by one-way ANOVA). (E) Loss of CRZ1 does not impact caspofungin-induced unmasking. Cells grown to mid-log phase prior to being exposed to 46.9ng/ml of caspofungin for 30 minutes and ß(1,3)-glucan exposure was subsequently assessed via flow cytometry. (n = 3 biological replicates)(ns = not significant, ****p<0.0001, by one-way ANOVA). (F) Loss of CRZ1 blocks calcium-induced masking. Overnight cultures of cells grown in the absence or presence of 50mM CaCl2 were stained for ß(1,3)-glucan exposure and flow cytometry was subsequently run to assess ß(1,3)-glucan exposure levels. (n = 3 biological replicates with 1 technical replicate for each)(**p<0.01, ****p<0.0001, by one-way ANOVA).CC BY · PubMed Central
Fig 3 Proposed model for calcineurin-regulated ß(1,3)-glucan exposure. Our data suggest that calcineurin serves as a switchboard in mediating ß(1,3)-glucan exposure in response to different stimuli: hyperactive STE11ΔN467 expression (black lines), caspofungin exposure (red lines), and high levels of exogenous calcium (blue lines). With regards to hyperactive STE11ΔN467 expression, we propose that activation of the downstream transcription factor Cph1 leads to increased expression of the cell wall sensor Dfi1 as well as architectural cell wall changes that are then sensed by these same Dfi1 proteins. This sensor in turn interacts with calmodulin to initiate signal transduction down a Dfi1/calmodulin/calcineurin signal transduction pathway and further increases ß(1,3)-glucan unmasking. In response to caspofungin exposure, calcineurin is also necessary to induce the full levels of unmasking observed in wild-type cells. Based on our data, calcineurin may act in a partially Dfi1 dependent manner, but an alternative regulator also mediates calcineurin activity in response to caspofungin treatment. Lastly, we propose that calcineurin is also capable of decreasing ß(1,3)-glucan exposure levels in response to growth in high levels of exogenous calcium, and is likely mediated via the canonical calmodulin/calcineurin/Crz1 signal transduction pathway. Dotted arrows indicate putative pathways that have not yet been experimentally confirmed.
Fig 3 Proposed model for calcineurin-regulated ß(1,3)-glucan exposure. Our data suggest that calcineurin serves as a switchboard in mediating ß(1,3)-glucan exposure in response to different stimuli: hyperactive STE11ΔN467 expression (black lines), caspofungin exposure (red lines), and high levels of exogenous calcium (blue lines). With regards to hyperactive STE11ΔN467 expression, we propose that activation of the downstream transcription factor Cph1 leads to increased expression of the cell wall sensor Dfi1 as well as architectural cell wall changes that are then sensed by these same Dfi1 proteins. This sensor in turn interacts with calmodulin to initiate signal transduction down a Dfi1/calmodulin/calcineurin signal transduction pathway and further increases ß(1,3)-glucan unmasking. In response to caspofungin exposure, calcineurin is also necessary to induce the full levels of unmasking observed in wild-type cells. Based on our data, calcineurin may act in a partially Dfi1 dependent manner, but an alternative regulator also mediates calcineurin activity in response to caspofungin treatment. Lastly, we propose that calcineurin is also capable of decreasing ß(1,3)-glucan exposure levels in response to growth in high levels of exogenous calcium, and is likely mediated via the canonical calmodulin/calcineurin/Crz1 signal transduction pathway. Dotted arrows indicate putative pathways that have not yet been experimentally confirmed.CC BY · PubMed Central
Fig 4 Key cell wall proteins mediate ß(1,3)-glucan exposure in C. albicans. (A) Comparative analysis of public data sets to identify conserved genes that are differentially regulated in conditions that involve calcineurin-mediated ß(1,3)-glucan exposure (STE11ΔN467 expression [36] and caspofungin exposure [55]) and fall within a predicted Crz1 regulon [29]. Gene ontology descriptions were taken from the Candida Genome Database. (B-D) Genetic analysis of conserved target genes identified during comparative analysis. Overnight cultures of cells were stained with anti-ß(1,3)-glucan antibody and a phycoerythrin-conjugated secondary antibody followed by flow cytometry analysis to assess the levels of ß(1,3)-glucan exposure. (B) ß(1,3)-glucan unmasking of fgr41Δ/Δ mutants. (C) ß(1,3)-glucan unmasking of cwp419Δ/Δ mutants. (D) ß(1,3)-glucan unmasking of PGA13 overexpression mutants. (n = 3 biological replicates with 1 technical replicate for each mutant analyzed)(****p<0.0001, by one-way ANOVA). (E) Representative microscopy images of ß(1,3)-glucan exposure of the fgr41Δ/Δ and cwp419Δ/Δ mutants. (The scale bar indicates 5μm).
Fig 4 Key cell wall proteins mediate ß(1,3)-glucan exposure in C. albicans. (A) Comparative analysis of public data sets to identify conserved genes that are differentially regulated in conditions that involve calcineurin-mediated ß(1,3)-glucan exposure (STE11ΔN467 expression [36] and caspofungin exposure [55]) and fall within a predicted Crz1 regulon [29]. Gene ontology descriptions were taken from the Candida Genome Database. (B-D) Genetic analysis of conserved target genes identified during comparative analysis. Overnight cultures of cells were stained with anti-ß(1,3)-glucan antibody and a phycoerythrin-conjugated secondary antibody followed by flow cytometry analysis to assess the levels of ß(1,3)-glucan exposure. (B) ß(1,3)-glucan unmasking of fgr41Δ/Δ mutants. (C) ß(1,3)-glucan unmasking of cwp419Δ/Δ mutants. (D) ß(1,3)-glucan unmasking of PGA13 overexpression mutants. (n = 3 biological replicates with 1 technical replicate for each mutant analyzed)(****p<0.0001, by one-way ANOVA). (E) Representative microscopy images of ß(1,3)-glucan exposure of the fgr41Δ/Δ and cwp419Δ/Δ mutants. (The scale bar indicates 5μm).CC BY · PubMed Central
Fig 5 FGR41 overexpression and deletion modulates Ste11ΔN467-induced, but not caspofungin-induced, ß(1,3)-glucan unmasking. (A-E) Overnight cultures of cells were stained with anti-ß(1,3)-glucan antibody and a phycoerythrin-conjugated secondary antibody to assess the levels of ß(1,3)-glucan exposure by flow cytometry. (A) ß(1,3)-glucan exposure during FGR41 overexpression. (B) ß(1,3)-glucan exposure in FGR41 deletion mutants. (C) ß(1,3)-glucan exposure during CWP419 overexpression. (D) ß(1,3)-glucan exposure in CWP419 deletion mutants (E) ß(1,3)-glucan exposure during PGA13 overexpression. (n = 3 biological replicates with 1 technical replicate for each mutant analyzed)(**p<0.005, ***p<0.0005, ****p<0.0001, by one-way ANOVA). (F-H) Cells grown to mid-log phase were exposed to 46.9ng/ml of caspofungin for 30 minutes and ß(1,3)-glucan exposure was subsequently assessed via flow cytometry. (F) ß(1,3)-glucan exposure of FGR41 overexpression cells treated with sublethal concentrations of caspofungin. (G) ß(1,3)-glucan exposure of CWP419 overexpression cells treated with sublethal concentrations of caspofungin. (H) ß(1,3)-glucan exposure of PGA13 overexpression cells treated with sublethal concentrations of caspofungin. (n = 3 biological replicates)(ns = not significant, ****p<0.0001, by one-way ANOVA).
Fig 5 FGR41 overexpression and deletion modulates Ste11ΔN467-induced, but not caspofungin-induced, ß(1,3)-glucan unmasking. (A-E) Overnight cultures of cells were stained with anti-ß(1,3)-glucan antibody and a phycoerythrin-conjugated secondary antibody to assess the levels of ß(1,3)-glucan exposure by flow cytometry. (A) ß(1,3)-glucan exposure during FGR41 overexpression. (B) ß(1,3)-glucan exposure in FGR41 deletion mutants. (C) ß(1,3)-glucan exposure during CWP419 overexpression. (D) ß(1,3)-glucan exposure in CWP419 deletion mutants (E) ß(1,3)-glucan exposure during PGA13 overexpression. (n = 3 biological replicates with 1 technical replicate for each mutant analyzed)(**p<0.005, ***p<0.0005, ****p<0.0001, by one-way ANOVA). (F-H) Cells grown to mid-log phase were exposed to 46.9ng/ml of caspofungin for 30 minutes and ß(1,3)-glucan exposure was subsequently assessed via flow cytometry. (F) ß(1,3)-glucan exposure of FGR41 overexpression cells treated with sublethal concentrations of caspofungin. (G) ß(1,3)-glucan exposure of CWP419 overexpression cells treated with sublethal concentrations of caspofungin. (H) ß(1,3)-glucan exposure of PGA13 overexpression cells treated with sublethal concentrations of caspofungin. (n = 3 biological replicates)(ns = not significant, ****p<0.0001, by one-way ANOVA).CC BY · PubMed Central
Fig 6 Loss of FGR41 attenuates virulence in a host immune system dependent manner. (A) ICR mice were intravenously infected with 1x106 cells of C. albicans wild-type (SC5314), the fgr41Δ/Δ mutant, or the fgr41Δ/ΔPENO1-FGR41 reintegrant strain, and kidneys were subsequently harvested 4 days post infection (d.p.i.) to assess fungal burden. (n = 7–8 mice per strain)(***p<0.0005, ****p<0.0001, by Kruskal-Wallis test with Dunn’s multiple comparisons post-hoc analysis). (B) Serum collected 4 d.p.i. was assessed via flow cytometry using the LEGENDplex cytokine bead-based array kit to measure circulatory cytokine levels following infection with either the C. albicans wild-type (SC5314) or the fgr41Δ/Δ mutant. (n = 5 mice)(The dashed line across the x-axis represents the limit of detection.)(ns = not significant, *p<0.05, **p<0.01, ***p = 0.0005, ****p<0.0001, by either student’s t-test or Mann-Whitney test). (C) ICR mice were intravenously infected with 1x106 cells of C. albicans wild-type (SC5314), the cwp419Δ/Δ mutant, or the cwp419Δ/ΔPENO1-CWP419 reintegrant strain, and kidneys were subsequently harvested 4 d.p.i. to assess fungal burden. (n = 6–8 mice per strain)(**p<0.01, by one-way ANOVA). (D) ICR mice were immunosuppressed with recurring intraperitoneal injections of 150mg/kg of cyclophosphamide every 3 days starting 4 days prior to infection. At day 0, mice were intravenously injected with 1x104 cells of C. albicans wild-type (SC5314) or the fgr41Δ/Δ mutant and kidneys were harvested 3 days post infection (d.p.i.) to assess fungal burden. (n = 6–7 mice)(ns = not significant, by Mann-Whitney test).
Fig 6 Loss of FGR41 attenuates virulence in a host immune system dependent manner. (A) ICR mice were intravenously infected with 1x106 cells of C. albicans wild-type (SC5314), the fgr41Δ/Δ mutant, or the fgr41Δ/ΔPENO1-FGR41 reintegrant strain, and kidneys were subsequently harvested 4 days post infection (d.p.i.) to assess fungal burden. (n = 7–8 mice per strain)(***p<0.0005, ****p<0.0001, by Kruskal-Wallis test with Dunn’s multiple comparisons post-hoc analysis). (B) Serum collected 4 d.p.i. was assessed via flow cytometry using the LEGENDplex cytokine bead-based array kit to measure circulatory cytokine levels following infection with either the C. albicans wild-type (SC5314) or the fgr41Δ/Δ mutant. (n = 5 mice)(The dashed line across the x-axis represents the limit of detection.)(ns = not significant, *p<0.05, **p<0.01, ***p = 0.0005, ****p<0.0001, by either student’s t-test or Mann-Whitney test). (C) ICR mice were intravenously infected with 1x106 cells of C. albicans wild-type (SC5314), the cwp419Δ/Δ mutant, or the cwp419Δ/ΔPENO1-CWP419 reintegrant strain, and kidneys were subsequently harvested 4 d.p.i. to assess fungal burden. (n = 6–8 mice per strain)(**p<0.01, by one-way ANOVA). (D) ICR mice were immunosuppressed with recurring intraperitoneal injections of 150mg/kg of cyclophosphamide every 3 days starting 4 days prior to infection. At day 0, mice were intravenously injected with 1x104 cells of C. albicans wild-type (SC5314) or the fgr41Δ/Δ mutant and kidneys were harvested 3 days post infection (d.p.i.) to assess fungal burden. (n = 6–7 mice)(ns = not significant, by Mann-Whitney test).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 83 references

Cited by

See all 12

Metadata

Authors
Wagner, A. S., Lumsdaine, S. W., Mangrum, M. M., King, A. E., Hancock, T. J., Sparer, T. E., & Reynolds, T. B.
Affiliations
University of Tennessee at Knoxville (US)
Corresponding author
Reynolds, Todd B.
Venue
PLOS Genetics
Published
2022-09-19
Volume
18
Issue
9
Pages
e1010405
ISSN
  • 1553-7390 (ISSN-L)
  • 1553-7404
OpenAlex
W4296331110
Cited by
12
References
83
Citations by year
2026: 1 · 2025: 6 · 2024: 2 · 2023: 3
FWCI
0.90
Type
journal article
Language
en
Open access
Locations
  • PLoS Genetics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (1R01AI53599-01, 1R15AI144683-01)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Keywords
Candida albicans, calcineurin, immune evasion, caspofungin, extracellular calcium, cell wall proteins, virulence attenuation, systemic infection, immunosuppression
MeSH terms
Caspofungin, Animals, Calcium, Candida albicans, Cell Wall, Fungal Proteins, Glucans, Calcineurin, beta-Glucans, Mitogen-Activated Protein Kinase 3, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cek1 regulates ß(1,3)-glucan exposure through calcineurin effectors in Candida albicans. https://app.cochat.ai/papers/10.1371/journal.pgen.1010405
The paper
Wagner, A. S., Lumsdaine, S. W., Mangrum, M. M., King, A. E., Hancock, T. J., Sparer, T. E., & Reynolds, T. B. (2022). Cek1 regulates ß(1,3)-glucan exposure through calcineurin effectors in Candida albicans. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1010405

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.